JENNIFER MAZUR: Open Payments
NPI 1861170664 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $285 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $174 |
| Insmed, Inc. | 4 | $69 |
| Verona Pharma, Inc. | 2 | $52 |
| Grifols USA, LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| GENZYME CORPORATION | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: TEZSPIRE, OFEV, Arikayce, Ohtuvayre, Prolastin-C Liquid, JASCAYD, MOUNJARO, DUPIXENT.
Industry payments across NY — which companies pay providers there.
